Psychedelics & Mental Health: Spanish Study Findings

As psychedelic research continues its slow re-entry into mainstream science, one major gap has persisted: who gets studied. For decades, most clinical research on substances like psilocybin and LSD has focused on White, English-speaking participants, leaving entire communities underrepresented. A newly published study¹ in Psychedelics helps address that imbalance by examining how Spanish-speaking adults across multiple countries report changes in depression, anxiety, and substance use after a meaningful psychedelic experience.

The findings offer both hope and nuance. They suggest that psychedelics may support mental health improvement in diverse populations, but also that how the experience unfolds matters just as much as the substance itself.

Study Methodology & Demographics

The research surveyed 404 Spanish-speaking adults from around the world, with most participants living in Mexico, the United States, and Colombia. The average age was 30, and participants were asked to reflect on their most memorable psychedelic experience involving either psilocybin or LSD.

Rather than focusing on laboratory-based therapy sessions, the study captured real-world experiences. Participants completed validated questionnaires that assessed emotional, psychological, mystical, and challenging aspects of their psychedelic journeys, as well as self-reported changes in mental health symptoms following the experience.

Importantly, the study centered on people who already identified as having conditions such as depression, anxiety, alcohol use disorder, or drug use disorder before their psychedelic experience.

Key Findings: Depression, Anxiety, & Substance Use

Among participants who reported having a mental health condition prior to their psychedelic experience, a large majority said their symptoms improved afterward. More than 80 percent of those with depression reported feeling better, while nearly three-quarters of participants with anxiety said their symptoms improved. Similar patterns emerged for substance use, with many individuals reporting reduced struggles with alcohol or other drugs.

These numbers do not prove that psychedelics “cure” mental health conditions, but they do suggest a strong association between psychedelic experiences and perceived improvements, especially in populations that are rarely centered in research.

Psychological Insight vs. Mystical Experience

Swipe to scroll →

One of the most striking findings from the study challenges a popular assumption in psychedelic culture: that mystical or transcendental experiences are the primary drivers of healing.

Instead, the strongest predictor of positive mental health outcomes was psychological insight. Participants who described moments of clarity, self-understanding, or new perspectives during their psychedelic experience were significantly more likely to report improvements in depression, anxiety, and substance use.

In contrast, classic mystical experiences, such as feelings of unity, ego dissolution, or transcendence, were not consistently linked to better outcomes. In fact, they were unexpectedly associated with lower odds of improvement in alcohol and drug use symptoms.

This finding suggests that personal meaning-making and emotional insight may be more therapeutically relevant than peak spiritual experiences alone. For clinicians and researchers, it reinforces the idea that integration, reflection, and psychological processing are critical components of psychedelic healing.

The Role of Comfort, Safety, and Emotional Tone

The study also examined the impact of challenging experiences during psychedelic use. Participants who reported intense fear, physical distress, feelings of losing control, grief, or isolation were less likely to report improvements in their mental health.

On the other hand, sensing a benign or comforting presence during the experience was associated with reduced depressive symptoms. This points to the importance of emotional safety, both internal and external, during psychedelic experiences.

Taken together, these findings align with growing evidence that “set and setting” are not just cultural buzzwords, but central factors in whether a psychedelic experience leads to healing or distress.

Bridging the Research Equity Gap

Beyond its clinical insights, this research is significant because of who it centers. Spanish-speaking communities, many of whom are part of broader BIPOC populations, have long been excluded from psychedelic science despite rich cultural histories involving entheogens.

By using Spanish-validated assessment tools and focusing specifically on Spanish-speaking adults, this study helps broaden the scientific understanding of how psychedelics affect diverse populations. It also underscores the importance of culturally responsive research as psychedelic therapies move closer to legalization and clinical use.

Inclusive research is not just about fairness; it’s about accuracy. Without diverse data, treatment models risk being incomplete or ineffective for large segments of the population.

Important Limitations to Keep in Mind

Like many early psychedelic studies, this research has limitations. It relied on retrospective self-reporting, meaning participants reflected on past experiences rather than being observed in real time. There is also the possibility of self-selection bias, as individuals who had positive experiences may have been more likely to participate.

Still, these limitations do not negate the study’s value. Instead, they highlight the need for future prospective and culturally inclusive clinical trials that build on these findings.

Implications for Psychedelic Therapy

This study adds to a growing body of evidence suggesting that psychedelics may offer meaningful mental health benefits, but not in a one-size-fits-all way. Psychological insight, emotional safety, and cultural context appear to play a decisive role in whether an experience leads to lasting improvement.

For Spanish-speaking communities, the research represents an important step toward visibility, validation, and inclusion in psychedelic science. For the broader field, it reinforces a key lesson: healing is not just about chemistry; it’s about meaning.

As psychedelic research continues to evolve, studies like this help ensure that the future of mental health innovation is not only effective but also inclusive.

References:

^{1. Armstrong, S. B., DellaCrosse, M., Fuentes-Balderrama, J., Lancelotta, R., & Davis, A. K. (2025). Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience. Psychedelics, 2, Article 100006. https://doi.org/10.1016/j.psyche.2025.100006}